PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 9, 2014British Journal of Clinical Pharmacology31 citationsOpen Access

An individual patient data meta‐analysis on factors associated with adverse drug events in surgical and non‐surgical inpatients

EBEveline B. BoekerKRK RamJKJoanna E. Klopotowska

Key Result

Patients aged 77 years or older experienced significantly more adverse drug events during hospital admission compared with patients aged 52 years or younger (OR 2.12).

Study Design

Type

Meta-Analysis (n=5,367)

Multicenter

Yes

Structured PICO

What patient characteristics and medications are associated with adverse drug events in hospitalized patients?

P
Population
5,367 adult surgical and non-surgical inpatients from four prospective observational studies, evaluated for factors associated with adverse drug events during hospital admission.
O
Outcome
Occurrence of adverse drug events (ADEs) and preventable ADEs (pADEs) during hospital admissionsafety

Elderly patients with polypharmacy on admission and receiving high-risk drugs are more prone to experiencing adverse drug events, highlighting the need for targeted vigilance systems.

Main Result

Odds Ratio: 2.12 (95% CI 1.7–2.65)

p-value: p=<0.05

Limitations

  • Diversity of included studies with varying population sizes, with one study contributing 56% of the population.
  • Minor differences in study design and recorded variables limited the number of corresponding variables that could be harmonized.
  • Inability to include potential confounders like morbidity, disease status (e.g., ASA classification, BMI), or social class due to missing data across datasets.
  • Length of hospital stay could not be used as a predictive factor because it develops during the stay and is affected by ADEs.
  • Differences in ADE detection methods across the included studies, such as varying use of trigger tools versus chart review.

Abstract

AIM: The incidence of adverse drug events (ADEs) in surgical and non-surgical patients may differ. This individual patient data meta-analysis (IPDMA) identifies patient characteristics and types of medication most associated with patients experiencing ADEs and suggests target areas for reducing harm and implementing focused interventions. METHODS: Authors of eligible studies on preventable ADEs (pADEs) were approached for collaboration. For assessment of differences among (non-)surgical patients and identification of associated factors descriptive statistics, Pearson chi-square, Poisson and logistic regression analyses were performed. For identification of high risk drugs (HRDs), a model was developed based on frequency, severity and preventability of medication related to ADEs. RESULTS: Included were 5367 patients from four studies. Patients aged ≥ 77 years experienced more ADEs and pADEs compared with patients aged ≤ 52 years (odds ratios (OR) 2.12 (95% CI 1.70, 2.65) and 2.55 (95% CI 1.70, 3.84), respectively, both P < 0.05). Polypharmacy on admission also increased the risk of ADEs (OR 1.21 (95% CI 1.03, 1.44), P < 0.05) and pADEs (OR 1.85 (95% CI 1.34, 2.56), P < 0.05). pADEs were associated with more severe harm than non-preventable ADEs (54% vs. 32%, P < 0.05). The top five HRDs were antibiotics, sedatives, anticoagulants, diuretics and antihypertensives. Events associated with HRDs included diarrhoea or constipation, abnormal liver function test and central nervous system events. Most pADEs resulted from prescribing errors (90%). CONCLUSION: Elderly patients with polypharmacy on admission and receiving antibiotics, sedatives, anticoagulants, diuretics or antihypertensives were more prone to experiencing ADEs. Efficiency in prevention of ADEs may be improved by targeted vigilance systems for alertness of physicians and pharmacists.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Boeker et al. (2014) conducted a meta-analysis in Adverse drug events in hospitalized patients (n=5,367). Age ≥ 77 years vs. Age ≤ 52 years was evaluated on Adverse drug events (ADEs) (OR 2.12, 95% CI 1.70-2.65, p=<0.05). Patients aged 77 years or older experienced significantly more adverse drug events during hospital admission compared with patients aged 52 years or younger (OR 2.12).

synapsesocial.com/papers/6a9cbb97ad9297026eb676a1https://doi.org/10.1111/bcp.12504
Ask AI
Helpful
Bookmark
Share
View Full Paper